臨床婦人科産科76巻8号

2022年08月発行

今月の臨床 HPVワクチン勧奨再開―いま知りたいことのすべて HPVと子宮頸がん・HPV関連疾患

再発性呼吸器乳頭腫症・中咽頭がん

著者： 室野重之¹

所属機関： ¹福島県立医科大学医学部耳鼻咽喉科学講座

ページ範囲：P.746 - P.752

●再発性呼吸器乳頭腫症は，多発しやすい，また再発しやすい，主に喉頭に発生する良性腫瘍であり，HPV6やHPV11に起因することが多い．

●中咽頭がんとHPVの関連が注目されており，本邦でも中咽頭がんの半数以上はHPV関連となり，急増している．

●ワクチン接種により若年型の再発性呼吸器乳頭腫症の発症率が低下することを示す海外の報告が出始めた．

●ワクチン接種による中咽頭がんの発生率に関する報告はまだないが，口腔HPV感染率は低下することが報告されている．

参考文献

1）Steinberg BM, et al : Laryngeal papillomavirus infection during clinical remission. N Engl J Med 308 : 1261-1264, 1983

2）Omland T, et al : Epidemiological aspects of recurrent respiratory papillomatosis : a population-based study. Laryngoscope 122 : 1595-1599, 2012

3）Novakovic D, et al : Juvenile recurrent respiratory papillomatosis : 10-year audit and Australian prevalence estimates. Laryngoscope 126 : 2827-2832, 2016

4）Seedat RY, et al : Age of diagnosis, incidence and prevalence of recurrent respiratory papillomatosis ― a South African perspective. Clin Otolaryngol 43 : 533-537, 2018

5）San Giorgi MRM, et al : Age of onset of recurrent respiratory papillomatosis : a distribution analysis. Clin Otolaryngol 41 : 448-453, 2016

6）Drolet M, et al : Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes : updated systematic review and meta-analysis. Lancet 394 : 497-509, 2019

7）Lukács A, et al : The quadrivalent HPV vaccine is protective against genital warts : a meta-analysis. BMC Public Health 20 : 691, 2020

8）Novakovic D, et al : A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of national HPV vaccination program. J Infec Dis 217 : 208-212, 2018

9）Meites E, et al : Significant declines in juvenile-onset recurrent respiratory papillomatosis following human papillomavirus（HPV）vaccine introduction in the United States. Clin Infect Dis 73 : 885-890, 2021

10）Rosenberg T, et al : Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis : a systematic review and meta-analysis. J Infect Dis 219 : 1016-1025, 2019

11）Snijders PJ, et al : Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 51 : 845-850, 1992

12）Ang KK, et al : Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363 : 24-35, 2010

13）Chaturvedi AK, et al : Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29 : 4294-4301, 2011

14）Hama T, et al : Prevalence of human papillomavirus in oropharyngeal cancer : a multicenter study in Japan. Oncology 87 : 173-182, 2014

15）Nguyen NP, et al : Oral sex and oropharyngeal cancer : the role of the primary care physicians. Medicine（Baltimore） 95 : e4228, 2016

16）D'Souza G, et al : Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356 : 1944-1956, 2007

17）Gillison ML, et al : Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 307 : 693-703, 2012

18）Tsentemeidou A, et al : Human papillomavirus vaccine to end oropharyngeal cancer. A systematic review and meta-analysis. Sex Transm Dis 48 : 700-707, 2021

19）Yoshida H, et al : Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer. Acta Otolaryngol 137 : 773-777, 2017

20）Gipson BJ, et al : Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer. Oral Oncol 77 : 52-56, 2018